3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Lung Neoplasms
29
Ovarian Neoplasms
27
Fallopian Tube Neoplasms
24
Carcinoma, Non-Small-Cell Lung
23
Colorectal Neoplasms
16
Melanoma
12
Carcinoma, Renal Cell
12
Carcinoma, Hepatocellular
12
Squamous Cell Carcinoma of Head and Neck
11
Pancreatic Neoplasms
11
Glioblastoma
11
Breast Neoplasms
11
Triple Negative Breast Neoplasms
10
Urinary Bladder Neoplasms
8
Prostatic Neoplasms
8
Neoplasm Metastasis
8
Uterine Cervical Neoplasms
7
Brenner Tumor
7
Mycosis Fungoides
6
Colonic Neoplasms
6
Brain Neoplasms
6
Rectal Neoplasms
5
Multiple Myeloma
5
Lymphoma, T-Cell, Cutaneous
5
Endometrial Neoplasms
5
Sezary Syndrome
4
Sarcoma
4
Neoplasms
4
Nasopharyngeal Carcinoma
4
Lymphoma, Large B-Cell, Diffuse
4
Interventions
Ifosfamide
30
Methotrexate
27
Doxorubicin
25
Cyclophosphamide
24
Cisplatin
22
Filgrastim
18
Etoposide
17
Gemcitabine
16
Leucovorin
14
Magnetic Resonance Spectroscopy
11
Temozolomide
10
cabozantinib
9
apatinib
9
Specimen Handling
9
Carboplatin
9
fludarabine
8
X-Rays
8
Nivolumab
8
Neoadjuvant Therapy
8
Irinotecan
8
Granulocyte Colony-Stimulating Factor
8
Docetaxel
8
Zoledronic Acid
7
Vincristine
7
Sirolimus
7
Radiotherapy
7
Phantoms, Imaging
7
Biopsy
7
Topotecan
6
Mesna
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Osteosarcoma
×
Immunoglobulin G
×
Clear all
NCT04668300
2026-04-15
DOSa
M.D. Anderson Cancer Center
Phase 2
Active not recruiting
75 enrolled